Appili Therapeutics Inc. — Form D
Appili Therapeutics Inc. of HALIFAX, A5, a company, filed a Form D exempt-offering notice with the SEC on 2016-12-30. The offering totals $15K, of which $15K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2016-12-30
- Form: D
- Accession: 0001693581-16-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $15K
- Amount sold: $15K
- Investors: 2
- Date of first sale: 2016-12-15
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-277398
Issuer
- Name: Appili Therapeutics Inc.
- CIK: 0001693581
- Entity type: Corporation
- Jurisdiction: CANADA (FEDERAL LEVEL)
- Incorporated: 2015
- Address: 21-1344 SUMMER ST., HALIFAX, A5, B3H 0A8
- Phone: 902-442-4655
Officers, directors & promoters (16)
| Name | Role | Location |
|---|
| Brian Bloom | Director | Toronto, A6 |
| John Holyoake | Director | Toronto, A6 |
| Lidija Marusic | Director | Halifax, A5 |
| Kevin Sullivan | Director | SAN RAMON, CA |
| John Holyoake | Executive Officer | Toronto, A6 |
| Kimberly Stephens | Executive Officer | Halifax, A5 |
| Kevin Sullivan | Executive Officer | SAN RAMON, CA |
| Brian Bloom | Promoter | Toronto, A6 |
| ROCHELLE C STENZLER | Director | HALIFAX, A5 |
| THERESA C MATKOVITS | Director | HALIFAX, A5 |
| IAN C MORTIMER | Director | HALIFAX, A5 |
| JUERGEN C FROEHLICH | Director | HALIFAX, A5 |
| BRIAN M BLOOM | Director | HALIFAX, A5 |
| KIMBERLY D STEPHENS | Executive Officer | HALIFAX, A5 |
| ARMAND C BALBONI | Director | HALIFAX, A5 |
| ARMAND C BALBONI | Executive Officer | HALIFAX, A5 |
Other filings by this issuer (2)
More